<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2021.112090</article-id><article-id pub-id-type="publisher-id">ACM-40549</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20210200000_99409481.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  肝移植物再利用在肝移植术中的文献分析报告
  Literature Analysis Report of the Reuse of Liver Graft in Liver Transplantation
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>于</surname><given-names>婷</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>饶</surname><given-names>伟</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>党</surname><given-names>智萍</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>翟</surname><given-names>慧敏</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>孔</surname><given-names>心涓</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>青岛大学附属医院器官移植中心肝脏病中心，青岛大学移植医学研究所，山东 青岛</addr-line></aff><aff id="aff2"><addr-line>青岛大学附属医院消化内科，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>05</day><month>02</month><year>2021</year></pub-date><volume>11</volume><issue>02</issue><fpage>617</fpage><lpage>625</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    目的：探讨移植器官在肝移植术中再利用的现状及前景。方法：检索中国知网、维普、万方、PubMed及Science Direct数据库相关文献。中文检索词为“移植器官/肝移植物 + 再利用/重复利用 + 肝移植”；英文检索词为“reuse”and“graft or liver graft”and“liver transplantation”。收录时间截至2020年6月15日。分析符合研究纳入标准的相关文献报告，统计肝移植物的供体、第一和第二接受者的临床资料。结果：经筛选，目前国际上已有19篇共计27例次重复使用肝移植物的个案报道。肝移植物的供体的年龄范围为8~69岁，其脑死亡原因主要为脑外伤(41%, 11/27)和脑血管意外(26%, 7/27)，另有胰岛素中毒1例，丙戊酸中毒1例，脑脓肿1例以及活体捐赠1例，余5例原因不详。第一接受者的年龄范围为4~65岁，其原发病分别为肝硬化失代偿期占48% (13/27)，急性肝衰竭占37% (10/27)，肝移植术后慢性排斥反应7% (2/27)，原发性硬化性胆管炎和布加综合征致肝衰竭各4% (1/27)；而当这些第一接受者在肝移植后出现不可逆的神经系统病变导致脑死亡时，随之就成为了第二接受者的供体。第一接受者最常见的脑死亡原因是移植后发生脑血管意外(56%, 15/27)，其次为脑水肿(30%, 8/27)，此外，还包括脑缺氧、脑疝和头枪击伤各1例，余1例原因不详。再次移植距初次移植的中位间隔时间为5天(1天~13年)。再次移植的中位冷缺血时间和中位热缺血时间分别为3.9 h (0.4 h~12.4 h)和0.9 h (0.6 h~1.5 h)。第二接受者的年龄范围是29~62岁；肝硬化合并肝细胞癌(33%, 9/27)和肝硬化失代偿期(26%, 7/27)在肝移植物的再利用指征中，分列第一位和第二位。总体来看，肝移植物再利用术后1年，3年及5年生存率分别为92.4%，80.5%和64.4%；中位随访时间为16个月(1.3~125个月)。结论：据现有文献报道分析，移植物再利用在肝移植领域应用的效果尚可，但仍需更大样本数据的支持。
    Objective: To investigate the current status and prospects of the reuse of grafts in liver transplantation. Methods: Relevant literature review was performed from Wanfang data, China National Knowledge Infrastructure (CNKI), Chongqing VIP, PubMed and Science Direct. The deadline for retrieval time was until June 15, 2020. the Chinese search terms were “graft” or “liver graft”; “reuse”; “liver transplantation”; the English search terms were “reuse” and “graft” or “liver graft” and “liver transplantation”; literature reports related to the reuse of liver grafts meeting the study criteria were analyzed, and the clinical data of donors for liver grafts, first and second recipients were counted. Results: After literature screening, 19 articles were eventually selected including 27 cases of the reuse of liver grafts in liver transplantation. The age range of donors for liver grafts was 8~69 years old; the main causes of their brain death are brain trauma (41%, 11/27) and cerebrovascular accidents (26%, 7/27). The age range of the first recipients ranged from 4 to 65 years, with 48% (13/27) of primary cirrhosis, 37% (10/27) of acute liver failure, 7% (2/27) of chronic rejection after liver transplantation, 4% (1/27) of primary sclerosing cholangitis and 4% (1/27) of Budd-Chiari syndrome. These first recipients became the donors of second recipients when they had developed irreversible neurological changes leading to brain death after liver transplantation. The most common cause of brain death in the first recipient was cerebrovascular accident after transplantation (56%, 15/27), followed by cerebral edema (30%, 8/27), in addition, there was also cerebral hypoxia, cerebral hernia and gunshot wound in 1 case each, and the cause of the remaining 1 case was unknown. The median interval between retransplantation and primary transplantation was 5 days (1~13 years). The median cold ischemia time and the median hot ischemia time were 3.9 h (0.4 h~12.4 h) and 0.9 h (0.6 h~1.5 h), respectively. The age range for the second recipients was 29~62 years; The main indications for reusing liver grafts were cirrhosis with hepatocellular carcinoma (33%, 9/27) and decompensated cirrhosis (26%, 7/27). Overall, the 1-year, 3-year, and 5-year survival rates after liver graft reuse were 92.4%, 80.5%, and 64.4%, respectively. The median follow-up was 16 months (1.3~125 months).Conclusions: According to the analysis of the existing literature, the application effect of the reuse of grafts in the field of liver transplantation is fair, but it still needs to be supported by larger sample data. 
  
 
</p></abstract><kwd-group><kwd>肝移植物，再利用，移植器官，肝移植，文献分析, Liver Graft</kwd><kwd> Reuse</kwd><kwd> Organ Transplantation</kwd><kwd> Liver Transplantation</kwd><kwd> Literature Analysis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>目的：探讨移植器官在肝移植术中再利用的现状及前景。方法：检索中国知网、维普、万方、PubMed及Science Direct数据库相关文献。中文检索词为“移植器官/肝移植物 + 再利用/重复利用 + 肝移植”；英文检索词为“reuse”and“graft or liver graft”and“liver transplantation”。收录时间截至2020年6月15日。分析符合研究纳入标准的相关文献报告，统计肝移植物的供体、第一和第二接受者的临床资料。结果：经筛选，目前国际上已有19篇共计27例次重复使用肝移植物的个案报道。肝移植物的供体的年龄范围为8~69岁，其脑死亡原因主要为脑外伤(41%, 11/27)和脑血管意外(26%, 7/27)，另有胰岛素中毒1例，丙戊酸中毒1例，脑脓肿1例以及活体捐赠1例，余5例原因不详。第一接受者的年龄范围为4~65岁，其原发病分别为肝硬化失代偿期占48% (13/27)，急性肝衰竭占37% (10/27)，肝移植术后慢性排斥反应7% (2/27)，原发性硬化性胆管炎和布加综合征致肝衰竭各4% (1/27)；而当这些第一接受者在肝移植后出现不可逆的神经系统病变导致脑死亡时，随之就成为了第二接受者的供体。第一接受者最常见的脑死亡原因是移植后发生脑血管意外(56%, 15/27)，其次为脑水肿(30%, 8/27)，此外，还包括脑缺氧、脑疝和头枪击伤各1例，余1例原因不详。再次移植距初次移植的中位间隔时间为5天(1天~13年)。再次移植的中位冷缺血时间和中位热缺血时间分别为3.9 h (0.4 h~12.4 h)和0.9 h (0.6 h~1.5 h)。第二接受者的年龄范围是29~62岁；肝硬化合并肝细胞癌(33%, 9/27)和肝硬化失代偿期(26%, 7/27)在肝移植物的再利用指征中，分列第一位和第二位。总体来看，肝移植物再利用术后1年，3年及5年生存率分别为92.4%，80.5%和64.4%；中位随访时间为16个月(1.3~125个月)。结论：据现有文献报道分析，移植物再利用在肝移植领域应用的效果尚可，但仍需更大样本数据的支持。</p></sec><sec id="s2"><title>关键词</title><p>肝移植物，再利用，移植器官，肝移植，文献分析</p></sec><sec id="s3"><title>Literature Analysis Report of the Reuse of Liver Graft in Liver Transplantation</title><p>Ting Yu<sup>1</sup>, Wei Rao<sup>2</sup>, Zhiping Dang<sup>1</sup>, Huimin Zhai<sup>1</sup>, Xinjuan Kong<sup>1*</sup></p><p><sup>1</sup>Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao Shandong</p><p><sup>2</sup>Organ Transplant Center, Liver Disease Center, The Affiliated Hospital of Qingdao University, Institute of Transplant Medicine, Qingdao University, Qingdao Shandong</p><p><img src="//html.hanspub.org/file/29-1571958x5_hanspub.png" /></p><p>Received: Jan. 17<sup>th</sup>, 2021; accepted: Feb. 2<sup>nd</sup>, 2021; published: Feb. 24<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/29-1571958x6_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Objective: To investigate the current status and prospects of the reuse of grafts in liver transplantation. Methods: Relevant literature review was performed from Wanfang data, China National Knowledge Infrastructure (CNKI), Chongqing VIP, PubMed and Science Direct. The deadline for retrieval time was until June 15, 2020. the Chinese search terms were “graft” or “liver graft”; “reuse”; “liver transplantation”; the English search terms were “reuse” and “graft” or “liver graft” and “liver transplantation”; literature reports related to the reuse of liver grafts meeting the study criteria were analyzed, and the clinical data of donors for liver grafts, first and second recipients were counted. Results: After literature screening, 19 articles were eventually selected including 27 cases of the reuse of liver grafts in liver transplantation. The age range of donors for liver grafts was 8~69 years old; the main causes of their brain death are brain trauma (41%, 11/27) and cerebrovascular accidents (26%, 7/27). The age range of the first recipients ranged from 4 to 65 years, with 48% (13/27) of primary cirrhosis, 37% (10/27) of acute liver failure, 7% (2/27) of chronic rejection after liver transplantation, 4% (1/27) of primary sclerosing cholangitis and 4% (1/27) of Budd-Chiari syndrome. These first recipients became the donors of second recipients when they had developed irreversible neurological changes leading to brain death after liver transplantation. The most common cause of brain death in the first recipient was cerebrovascular accident after transplantation (56%, 15/27), followed by cerebral edema (30%, 8/27), in addition, there was also cerebral hypoxia, cerebral hernia and gunshot wound in 1 case each, and the cause of the remaining 1 case was unknown. The median interval between retransplantation and primary transplantation was 5 days (1~13 years). The median cold ischemia time and the median hot ischemia time were 3.9 h (0.4 h~12.4 h) and 0.9 h (0.6 h~1.5 h), respectively. The age range for the second recipients was 29~62 years; The main indications for reusing liver grafts were cirrhosis with hepatocellular carcinoma (33%, 9/27) and decompensated cirrhosis (26%, 7/27). Overall, the 1-year, 3-year, and 5-year survival rates after liver graft reuse were 92.4%, 80.5%, and 64.4%, respectively. The median follow-up was 16 months (1.3~125 months).Conclusions: According to the analysis of the existing literature, the application effect of the reuse of grafts in the field of liver transplantation is fair, but it still needs to be supported by larger sample data.</p><p>Keywords:Liver Graft, Reuse, Organ Transplantation, Liver Transplantation, Literature Analysis</p><disp-formula id="hanspub.40549-formula43"><graphic xlink:href="//html.hanspub.org/file/29-1571958x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/29-1571958x8_hanspub.png" /> <img src="//html.hanspub.org/file/29-1571958x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>由于移植器官供体的短缺和对器官移植的临床需求不断增加，促使器官移植医务工作者不断尝试新的策略以扩大移植物的来源 [<xref ref-type="bibr" rid="hanspub.40549-ref1">1</xref>]。而移植器官的再利用，也是临床上缓解移植物短缺问题的策略之一。目前国际上对于移植器官再利用的研究，主要涉及肝脏、肾脏和心脏等方面，其中，肝脏移植物的再利用经验较为丰富，但也多局限于单个器官移植中心的病例报道 [<xref ref-type="bibr" rid="hanspub.40549-ref2">2</xref>] - [<xref ref-type="bibr" rid="hanspub.40549-ref20">20</xref>]。本文通过检索既往国内外关于肝移植物再利用的相关文献报道，总结分析这种移植物再利用的肝移植手术的临床经验，并探讨其应用前景，以供同行借鉴。</p></sec><sec id="s6"><title>2. 资料与方法</title><sec id="s6_1"><title>2.1. 检索方法</title><p>检索中国知网、维普、万方、PubMed及Science Direct数据库。收录时间截至2020年6月15日。英文检索词为“reuse”and“graft or liver graft”and“liver transplantation”；中文检索词为“移植器官/肝移植物 + 再利用/重复利用 + 肝移植”。文献检索及筛选流程见图1，最终纳入文献基本信息见表1和表2。纳入标准：文献中明确提供了关于肝移植物的供体以及第一和第二接受者的临床资料信息，包括其年龄，性别，原发疾病及预后，两次肝移植手术的时间间隔，再移植手术的热缺血时间和冷缺血时间。排除标准：资料不全文献、会议论文及重复个案报道。</p><p>图1. 纳入文献筛选流程及结果</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Basic information of the included literature (related to the first recipient</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >年份</th><th align="center" valign="middle"  rowspan="2"  >作者</th><th align="center" valign="middle"  colspan="3"  >肝移植物的供体</th><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="4"  >第一接受者(亦为第二接受者供体)</th></tr></thead><tr><td align="center" valign="middle" >年龄</td><td align="center" valign="middle" >性别</td><td align="center" valign="middle" >死因</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >性别</td><td align="center" valign="middle" >年龄</td><td align="center" valign="middle" >肝病</td><td align="center" valign="middle" >死因</td></tr><tr><td align="center" valign="middle" >1991年</td><td align="center" valign="middle" >Moreno G等 [<xref ref-type="bibr" rid="hanspub.40549-ref2">2</xref>]</td><td align="center" valign="middle" >40岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >脑外伤</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >57岁</td><td align="center" valign="middle" >原发性胆汁性肝硬化IV期</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >1996年</td><td align="center" valign="middle" >Moreno G等 [<xref ref-type="bibr" rid="hanspub.40549-ref2">2</xref>]</td><td align="center" valign="middle" >22岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >脑外伤</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >54岁</td><td align="center" valign="middle" >原发性硬化性胆管炎</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >1996年</td><td align="center" valign="middle" >Moreno G等 [<xref ref-type="bibr" rid="hanspub.40549-ref2">2</xref>]</td><td align="center" valign="middle" >23岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >脑外伤</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >51岁</td><td align="center" valign="middle" >肝移植术后慢性排斥反应</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >1996年</td><td align="center" valign="middle" >Tantawi B等 [<xref ref-type="bibr" rid="hanspub.40549-ref3">3</xref>]</td><td align="center" valign="middle" >24岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >车祸伤</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >24岁</td><td align="center" valign="middle" >肝移植术后慢性排斥反应</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >1997年</td><td align="center" valign="middle" >Friedrich J等 [<xref ref-type="bibr" rid="hanspub.40549-ref4">4</xref>]</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >隐源性肝硬化晚期</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >1997年</td><td align="center" valign="middle" >Figueras J等 [<xref ref-type="bibr" rid="hanspub.40549-ref5">5</xref>]</td><td align="center" valign="middle" >65岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >脑外伤</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >55岁</td><td align="center" valign="middle" >酒精性肝硬化晚期</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >2003年</td><td align="center" valign="middle" >Rubay R等 [<xref ref-type="bibr" rid="hanspub.40549-ref6">6</xref>]</td><td align="center" valign="middle" >15岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >胰岛素中毒</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >47岁</td><td align="center" valign="middle" >急性肝衰竭 (对乙酰氨基酚中毒)</td><td align="center" valign="middle" >脑水肿</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle" >2004年</th><th align="center" valign="middle" >Pruvot FR等 [<xref ref-type="bibr" rid="hanspub.40549-ref7">7</xref>]</th><th align="center" valign="middle" >48岁</th><th align="center" valign="middle" >男</th><th align="center" valign="middle" >脑卒中</th><th align="center" valign="middle" ></th><th align="center" valign="middle" >女</th><th align="center" valign="middle" >21岁</th><th align="center" valign="middle" >急性肝衰竭 (对乙酰氨基酚中毒)</th><th align="center" valign="middle" >脑水肿</th></tr></thead><tr><td align="center" valign="middle" >2005年</td><td align="center" valign="middle" >Ortiz J等 [<xref ref-type="bibr" rid="hanspub.40549-ref8">8</xref>]</td><td align="center" valign="middle" >51岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >车祸伤</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >56岁</td><td align="center" valign="middle" >丙肝肝硬化晚期</td><td align="center" valign="middle" >缺氧性脑损伤</td></tr><tr><td align="center" valign="middle" >2005年</td><td align="center" valign="middle" >Ortiz J等 [<xref ref-type="bibr" rid="hanspub.40549-ref8">8</xref>]</td><td align="center" valign="middle" >45岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >脑出血</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >35岁</td><td align="center" valign="middle" >急性肝衰竭 (对乙酰氨基酚中毒)</td><td align="center" valign="middle" >脑水肿</td></tr><tr><td align="center" valign="middle" >2005年</td><td align="center" valign="middle" >Ortiz J等 [<xref ref-type="bibr" rid="hanspub.40549-ref8">8</xref>]</td><td align="center" valign="middle" >27岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >脑外伤</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >60岁</td><td align="center" valign="middle" >隐源性肝硬化晚期</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >2006年</td><td align="center" valign="middle" >Castellote J等 [<xref ref-type="bibr" rid="hanspub.40549-ref9">9</xref>]</td><td align="center" valign="middle" >65岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >脑外伤</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >55岁</td><td align="center" valign="middle" >酒精性肝硬化晚期</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >2006年</td><td align="center" valign="middle" >Castellote J等 [<xref ref-type="bibr" rid="hanspub.40549-ref9">9</xref>]</td><td align="center" valign="middle" >64岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >脑出血</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >58岁</td><td align="center" valign="middle" >酒精性肝硬化晚期</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >2006年</td><td align="center" valign="middle" >Castellote J等 [<xref ref-type="bibr" rid="hanspub.40549-ref9">9</xref>]</td><td align="center" valign="middle" >37岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >脑脓肿</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >58岁</td><td align="center" valign="middle" >酒精性肝硬化晚期</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >2006年</td><td align="center" valign="middle" >Tayar C等 [<xref ref-type="bibr" rid="hanspub.40549-ref10">10</xref>]</td><td align="center" valign="middle" >35岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >车祸伤</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >59岁</td><td align="center" valign="middle" >酒精性肝硬化晚期</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >2007年</td><td align="center" valign="middle" >Nafidi O等 [<xref ref-type="bibr" rid="hanspub.40549-ref11">11</xref>]</td><td align="center" valign="middle" >56岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >脑出血</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >26岁</td><td align="center" valign="middle" >急性肝衰竭 (对乙酰氨基酚中毒)</td><td align="center" valign="middle" >脑疝</td></tr><tr><td align="center" valign="middle" >2009年</td><td align="center" valign="middle" >Olschewski P等 [<xref ref-type="bibr" rid="hanspub.40549-ref12">12</xref>]</td><td align="center" valign="middle" >42岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >脑出血</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >53岁</td><td align="center" valign="middle" >隐源性肝硬化晚期</td><td align="center" valign="middle" >脑水肿</td></tr><tr><td align="center" valign="middle" >2010年</td><td align="center" valign="middle" >Rentsch M等 [<xref ref-type="bibr" rid="hanspub.40549-ref13">13</xref>]</td><td align="center" valign="middle" >16岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >丙戊酸中毒</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >38岁</td><td align="center" valign="middle" >布加综合征致肝衰竭</td><td align="center" valign="middle" >脑血栓形成</td></tr><tr><td align="center" valign="middle" >2012年</td><td align="center" valign="middle" >Karabulut等 [<xref ref-type="bibr" rid="hanspub.40549-ref14">14</xref>]</td><td align="center" valign="middle" >8岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >脑外伤</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >4岁</td><td align="center" valign="middle" >急性肝衰竭(甲肝)</td><td align="center" valign="middle" >脑水肿</td></tr><tr><td align="center" valign="middle" >2013年</td><td align="center" valign="middle" >Desai CS等 [<xref ref-type="bibr" rid="hanspub.40549-ref15">15</xref>]</td><td align="center" valign="middle" >16岁</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >17岁</td><td align="center" valign="middle" >急性肝衰竭 (对乙酰氨基酚中毒)</td><td align="center" valign="middle" >脑水肿</td></tr><tr><td align="center" valign="middle" >2013年</td><td align="center" valign="middle" >Desai CS等 [<xref ref-type="bibr" rid="hanspub.40549-ref15">15</xref>]</td><td align="center" valign="middle" >17岁</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >17岁</td><td align="center" valign="middle" >急性肝衰竭 (对乙酰氨基酚中毒)</td><td align="center" valign="middle" >脑水肿</td></tr><tr><td align="center" valign="middle" >2013年</td><td align="center" valign="middle" >Desai CS等 [<xref ref-type="bibr" rid="hanspub.40549-ref15">15</xref>]</td><td align="center" valign="middle" >25岁</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >16岁</td><td align="center" valign="middle" >急性肝衰竭(未知药物)</td><td align="center" valign="middle" >枪击头部</td></tr><tr><td align="center" valign="middle" >2014年</td><td align="center" valign="middle" >Tanaka H等 [<xref ref-type="bibr" rid="hanspub.40549-ref16">16</xref>]</td><td align="center" valign="middle" >69岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >脑出血</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >55岁</td><td align="center" valign="middle" >丙肝肝硬化晚期</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >2015年</td><td align="center" valign="middle" >Balderramo D等 [<xref ref-type="bibr" rid="hanspub.40549-ref17">17</xref>]</td><td align="center" valign="middle" >20岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >脑外伤</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >65岁</td><td align="center" valign="middle" >急性肝衰竭</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >2015年</td><td align="center" valign="middle" >Wong TC等 [<xref ref-type="bibr" rid="hanspub.40549-ref18">18</xref>]</td><td align="center" valign="middle" >67岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >脑出血</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >49岁</td><td align="center" valign="middle" >乙肝肝硬化晚期</td><td align="center" valign="middle" >脑出血</td></tr><tr><td align="center" valign="middle" >2018年</td><td align="center" valign="middle" >Hu XG等 [<xref ref-type="bibr" rid="hanspub.40549-ref19">19</xref>]</td><td align="center" valign="middle" >30岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >活体捐赠</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >32岁</td><td align="center" valign="middle" >急性肝衰竭(甲肝)</td><td align="center" valign="middle" >脑水肿</td></tr><tr><td align="center" valign="middle" >2020年</td><td align="center" valign="middle" >Kim MJ等 [<xref ref-type="bibr" rid="hanspub.40549-ref20">20</xref>]</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >42岁</td><td align="center" valign="middle" >酒精性肝硬化</td><td align="center" valign="middle" >/</td></tr></tbody></table></table-wrap></table-wrap-group><p>表1. 纳入文献的基本信息(第一接受者相关)</p><p>注：/代表信息不详。</p><table-wrap-group id="2"><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Basic information of the included literature (related to the second recipient</title></caption><table-wrap id="2_1"><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >年份</th><th align="center" valign="middle"  rowspan="2"  >作者</th><th align="center" valign="middle"  rowspan="2"  >两次移植间隔时间</th><th align="center" valign="middle"  rowspan="2"  >冷缺血 时间</th><th align="center" valign="middle"  rowspan="2"  >热缺血 时间</th><th align="center" valign="middle"  colspan="4"  >第二接受者</th></tr></thead><tr><td align="center" valign="middle" >年龄</td><td align="center" valign="middle" >性别</td><td align="center" valign="middle" >肝病</td><td align="center" valign="middle" >结局</td></tr><tr><td align="center" valign="middle" >1991年</td><td align="center" valign="middle" >Moreno G等 [<xref ref-type="bibr" rid="hanspub.40549-ref2">2</xref>]</td><td align="center" valign="middle" >1 d</td><td align="center" valign="middle" >1.7 h</td><td align="center" valign="middle" >0.8 h</td><td align="center" valign="middle" >29岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >原发性硬化性胆管炎和胆管癌肝移植术后慢性排斥反应</td><td align="center" valign="middle" >术后48个月后死于 胆管癌复发</td></tr><tr><td align="center" valign="middle" >1996年</td><td align="center" valign="middle" >Moreno G等 [<xref ref-type="bibr" rid="hanspub.40549-ref2">2</xref>]</td><td align="center" valign="middle" >2 d</td><td align="center" valign="middle" >1.5 h</td><td align="center" valign="middle" >1.0 h</td><td align="center" valign="middle" >32岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >丙肝肝移植术后慢性排斥反应</td><td align="center" valign="middle" >术后4个月死于 败血症</td></tr><tr><td align="center" valign="middle" >1996年</td><td align="center" valign="middle" >Moreno G等 [<xref ref-type="bibr" rid="hanspub.40549-ref2">2</xref>]</td><td align="center" valign="middle" >2 d</td><td align="center" valign="middle" >1 h</td><td align="center" valign="middle" >0.9 h</td><td align="center" valign="middle" >56岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >丙肝肝硬化，肝细胞癌</td><td align="center" valign="middle" >术后25个月仍存活</td></tr><tr><td align="center" valign="middle" >1996年</td><td align="center" valign="middle" >Tantawi B等 [<xref ref-type="bibr" rid="hanspub.40549-ref3">3</xref>]</td><td align="center" valign="middle" >5 d</td><td align="center" valign="middle" >6 h</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >52岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >酒精肝肝硬化</td><td align="center" valign="middle" >术后6个月仍存活</td></tr><tr><td align="center" valign="middle" >1997年</td><td align="center" valign="middle" >Friedrich J等 [<xref ref-type="bibr" rid="hanspub.40549-ref4">4</xref>]</td><td align="center" valign="middle" >1 d</td><td align="center" valign="middle" >10 h</td><td align="center" valign="middle" >1 h</td><td align="center" valign="middle" >46岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >A型血友病行肝移植术后 复发性乙肝</td><td align="center" valign="middle" >术后5个月仍存活</td></tr><tr><td align="center" valign="middle" >1997年</td><td align="center" valign="middle" >Figueras J等 [<xref ref-type="bibr" rid="hanspub.40549-ref5">5</xref>]</td><td align="center" valign="middle" >5 d</td><td align="center" valign="middle" >11 h</td><td align="center" valign="middle" >0.9 h</td><td align="center" valign="middle" >58岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >丙肝肝硬化晚期</td><td align="center" valign="middle" >术后14个月仍存活</td></tr><tr><td align="center" valign="middle" >2003年</td><td align="center" valign="middle" >Rubay R等 [<xref ref-type="bibr" rid="hanspub.40549-ref6">6</xref>]</td><td align="center" valign="middle" >2 d</td><td align="center" valign="middle" >12.4 h</td><td align="center" valign="middle" >0.7 h</td><td align="center" valign="middle" >53岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >丙肝肝硬化，肝细胞癌</td><td align="center" valign="middle" >术后22个月仍存活</td></tr></tbody></table></table-wrap><table-wrap id="2_2"><table><tbody><thead><tr><th align="center" valign="middle" >2004年</th><th align="center" valign="middle" >Pruvot FR等 [<xref ref-type="bibr" rid="hanspub.40549-ref7">7</xref>]</th><th align="center" valign="middle" >2 d</th><th align="center" valign="middle" >5.1 h</th><th align="center" valign="middle" >1.5 h</th><th align="center" valign="middle" >61岁</th><th align="center" valign="middle" >女</th><th align="center" valign="middle" >丙肝肝硬化失代偿期</th><th align="center" valign="middle" >术后11个月仍存活</th></tr></thead><tr><td align="center" valign="middle" >2005年</td><td align="center" valign="middle" >Ortiz J等 [<xref ref-type="bibr" rid="hanspub.40549-ref8">8</xref>]</td><td align="center" valign="middle" >2 d</td><td align="center" valign="middle" >0.6 h</td><td align="center" valign="middle" >0.6 h</td><td align="center" valign="middle" >44岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >丙肝，酒精肝</td><td align="center" valign="middle" >术后25个月仍存活</td></tr><tr><td align="center" valign="middle" >2005年</td><td align="center" valign="middle" >Ortiz J等 [<xref ref-type="bibr" rid="hanspub.40549-ref8">8</xref>]</td><td align="center" valign="middle" >3 d</td><td align="center" valign="middle" >0.4 h</td><td align="center" valign="middle" >0.75 h</td><td align="center" valign="middle" >56岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >原发性硬化性胆管炎合并 肝肾综合征</td><td align="center" valign="middle" >术后12个月仍存活</td></tr><tr><td align="center" valign="middle" >2005年</td><td align="center" valign="middle" >Ortiz J等 [<xref ref-type="bibr" rid="hanspub.40549-ref8">8</xref>]</td><td align="center" valign="middle" >8 d</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >44岁</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >术后62个月仍存活</td></tr><tr><td align="center" valign="middle" >2006年</td><td align="center" valign="middle" >Castellote J等 [<xref ref-type="bibr" rid="hanspub.40549-ref9">9</xref>]</td><td align="center" valign="middle" >5 d</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >58岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >丙肝肝硬化晚期</td><td align="center" valign="middle" >术后125个月仍存活</td></tr><tr><td align="center" valign="middle" >2006年</td><td align="center" valign="middle" >Castellote J等 [<xref ref-type="bibr" rid="hanspub.40549-ref9">9</xref>]</td><td align="center" valign="middle" >14 d</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >55岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >布加综合征致肝衰竭</td><td align="center" valign="middle" >术后13个月仍存活</td></tr><tr><td align="center" valign="middle" >2006年</td><td align="center" valign="middle" >Castellote J等 [<xref ref-type="bibr" rid="hanspub.40549-ref9">9</xref>]</td><td align="center" valign="middle" >10 d</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >47岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >肝移植术后出现缺血性胆管炎合并肝性脑病</td><td align="center" valign="middle" >术后7月仍存活</td></tr><tr><td align="center" valign="middle" >2006年</td><td align="center" valign="middle" >Tayar C等 [<xref ref-type="bibr" rid="hanspub.40549-ref10">10</xref>]</td><td align="center" valign="middle" >4745 d</td><td align="center" valign="middle" >12 h</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >61岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >隐源性肝硬化晚期，肝细胞癌</td><td align="center" valign="middle" >术后12个月仍存活</td></tr><tr><td align="center" valign="middle" >2007年</td><td align="center" valign="middle" >Balderramo D等 [<xref ref-type="bibr" rid="hanspub.40549-ref11">11</xref>]</td><td align="center" valign="middle" >2 d</td><td align="center" valign="middle" >1.3 h</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >62岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >血色素沉着症相关肝硬化， 肝细胞癌</td><td align="center" valign="middle" >术后30个月仍存活</td></tr><tr><td align="center" valign="middle" >2009年</td><td align="center" valign="middle" >Olschewski P等 [<xref ref-type="bibr" rid="hanspub.40549-ref12">12</xref>]</td><td align="center" valign="middle" >1 d</td><td align="center" valign="middle" >2.4 h</td><td align="center" valign="middle" >1.0 h</td><td align="center" valign="middle" >43岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >酒精性肝硬化合并肝细胞癌</td><td align="center" valign="middle" >术后6月个仍存活</td></tr><tr><td align="center" valign="middle" >2010年</td><td align="center" valign="middle" >Rentsch M等 [<xref ref-type="bibr" rid="hanspub.40549-ref13">13</xref>]</td><td align="center" valign="middle" >1825 d</td><td align="center" valign="middle" >10.6 h</td><td align="center" valign="middle" >0.7 h</td><td align="center" valign="middle" >51岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >进行性多囊性肝病</td><td align="center" valign="middle" >术后18月个仍存活</td></tr><tr><td align="center" valign="middle" >2012年</td><td align="center" valign="middle" >Karabulut等 [<xref ref-type="bibr" rid="hanspub.40549-ref14">14</xref>]</td><td align="center" valign="middle" >5 d</td><td align="center" valign="middle" >1.4 h</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >31岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >隐源性肝硬化，肝细胞癌</td><td align="center" valign="middle" >术后1.3月死于 败血症和MODS</td></tr><tr><td align="center" valign="middle" >2013年</td><td align="center" valign="middle" >Desai CS等 [<xref ref-type="bibr" rid="hanspub.40549-ref15">15</xref>]</td><td align="center" valign="middle" >4 d</td><td align="center" valign="middle" >1.8 h</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >61岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >丙肝，肝细胞癌</td><td align="center" valign="middle" >术后34月仍存活</td></tr><tr><td align="center" valign="middle" >2013年</td><td align="center" valign="middle" >Desai CS等 [<xref ref-type="bibr" rid="hanspub.40549-ref15">15</xref>]</td><td align="center" valign="middle" >6 d</td><td align="center" valign="middle" >3 h</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >57岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >丙肝肝硬化，肝细胞癌</td><td align="center" valign="middle" >术后61月仍存活</td></tr><tr><td align="center" valign="middle" >2013年</td><td align="center" valign="middle" >Desai CS等 [<xref ref-type="bibr" rid="hanspub.40549-ref15">15</xref>]</td><td align="center" valign="middle" >1560 d</td><td align="center" valign="middle" >5 h</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >34岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >自免肝合并肝硬化， 1型糖尿病合并肾衰竭</td><td align="center" valign="middle" >术后14月死于败血症</td></tr><tr><td align="center" valign="middle" >2014年</td><td align="center" valign="middle" >Tanaka H等 [<xref ref-type="bibr" rid="hanspub.40549-ref16">16</xref>]</td><td align="center" valign="middle" >14 d</td><td align="center" valign="middle" >9 h</td><td align="center" valign="middle" >1.5 h</td><td align="center" valign="middle" >54岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >丙肝肝硬化，肝细胞癌</td><td align="center" valign="middle" >术后16月死于 肝细胞癌复发</td></tr><tr><td align="center" valign="middle" >2015年</td><td align="center" valign="middle" >Balderramo D等 [<xref ref-type="bibr" rid="hanspub.40549-ref17">17</xref>]</td><td align="center" valign="middle" >3 d</td><td align="center" valign="middle" >6.2 h</td><td align="center" valign="middle" >1.1 h</td><td align="center" valign="middle" >53岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >酒精性肝硬化，肝性脑病，肝肾综合征</td><td align="center" valign="middle" >术后24月仍存活</td></tr><tr><td align="center" valign="middle" >2015年</td><td align="center" valign="middle" >Wong TC等 [<xref ref-type="bibr" rid="hanspub.40549-ref18">18</xref>]</td><td align="center" valign="middle" >4015 d</td><td align="center" valign="middle" >4.8 h</td><td align="center" valign="middle" >0.7 h</td><td align="center" valign="middle" >34岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >乙肝肝硬化失代偿期合并肝性脑病</td><td align="center" valign="middle" >术后2月仍存活</td></tr><tr><td align="center" valign="middle" >2018年</td><td align="center" valign="middle" >Hu XG等 [<xref ref-type="bibr" rid="hanspub.40549-ref19">19</xref>]</td><td align="center" valign="middle" >7 d</td><td align="center" valign="middle" >1.1 h</td><td align="center" valign="middle" >0.6 h</td><td align="center" valign="middle" >43岁</td><td align="center" valign="middle" >男</td><td align="center" valign="middle" >乙肝肝硬化失代偿期</td><td align="center" valign="middle" >术后96月仍存活</td></tr><tr><td align="center" valign="middle" >2020年</td><td align="center" valign="middle" >Kim MJ等 [<xref ref-type="bibr" rid="hanspub.40549-ref20">20</xref>]</td><td align="center" valign="middle" >10 d</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >38岁</td><td align="center" valign="middle" >女</td><td align="center" valign="middle" >急性肝衰竭(草药)合并肝性脑病</td><td align="center" valign="middle" >术后36月仍存活</td></tr></tbody></table></table-wrap></table-wrap-group><p>表2. 纳入文献的基本信息(第二接受者相关)</p><p>注：d代表天数；h代表小时；/代表信息不详。</p></sec><sec id="s6_2"><title>2.2. 数据提取和文献质量评价</title><p>两名研究者独立阅读文献的题目和摘要(必要时阅读全文)进行筛选及纳入，如有分歧，则由第3位研究者决定。统计并分析肝移植物再利用的供体与第一和第二接受者的年龄，性别，原发疾病及预后，两次肝移植手术的时间间隔，再移植手术的热缺血时间和冷缺血时间。研究者需对纳入的文献和文献数据核对以确保一致。文献质量评价采用Joanna Briggs Institute (JBI)病例报告及病例系列质量评价表 [<xref ref-type="bibr" rid="hanspub.40549-ref21">21</xref>]。</p></sec></sec><sec id="s7"><title>3. 结果</title><p>按照纳入与排除标准，最终纳入19篇文献，共计27例次重复使用肝移植物的个案报道(表1、表2)。</p><p>经统计分析显示，肝移植物的供体的年龄范围为8~69岁，其脑死亡原因主要为脑外伤(41%, 11/27)和脑血管意外(26%, 7/27)，另有胰岛素中毒1例，丙戊酸中毒1例，脑脓肿1例以及活体捐赠1例，余5例原因不详。第一接受者的年龄范围为4~65岁，其原发病分别为肝硬化失代偿期占48% (13/27)，急性肝衰竭占37% (10/27)，肝移植术后慢性排斥反应7% (2/27)，原发性硬化性胆管炎和布加综合征致肝衰竭各4% (1/27)；而当这些第一接受者在肝移植后出现不可逆的神经系统病变导致脑死亡时，随之就成为了第二接受者的供体。第一接受者最常见的脑死亡原因是移植后发生脑血管意外(56%, 15/27)，其次为脑水肿(30%, 8/27)，此外，还包括脑缺氧、脑疝和头枪击伤各1例，余1例原因不详。</p><p>而在接受肝移植物再利用的第二接受者中，其适应证分别为：肝硬化合并肝细胞癌9例，肝硬化失代偿期7例，原发性硬化性胆管炎合并肝肾综合征1例，布加综合征导致肝衰竭1例，进行性多囊性肝病1例，自身免疫性肝炎肝硬化合并糖尿病及肾衰竭1例，急性肝衰竭1例，二次肝移植者5例(慢性排斥反应2例，乙肝复发1例，缺血性胆管炎合并肝性脑病1例，丙型病毒性肝炎肝合并酒精性肝炎1例)，余1例再利用原因不详。</p><p>再次移植距初次移植的中位间隔时间为5天(1天~13年)。再次移植的中位冷缺血时间和中位热缺血时间分别为3.9 h (0.4 h~12.4 h)和0.9 h (0.6 h~1.5 h)。移植物再利用术后1年，3年及5年生存率分别为92.4%，80.5%和64.4%；中位随访时间为16个月(1.3~125个月)。</p><p>据本研究结果，在共计27例次的移植物再利用的报道中，最终有5例死亡，其原因主要为肿瘤复发、败血症和多脏器功能衰竭。</p></sec><sec id="s8"><title>4. 讨论</title><sec id="s8_1"><title>4.1. 肝移植物的再利用标准</title><p>目前，关于如何选择再利用的肝移植物尚无统一标准。Moreno G等人 [<xref ref-type="bibr" rid="hanspub.40549-ref2">2</xref>] 认为，选择肝移植物再利用的参考标准有：(1) 肝移植物再利用的获取对象应年轻，且一般状态良好；(2) 在再利用移植物的获取对象被诊断为脑死亡后，其肝移植物仍具有良好的功能；(3) 尽可能缩短两次肝移植的时间间隔(&lt;48小时)，缩短再利用移植物的保存时间；(4) 供体–受体血型交叉配型结果为阴性，且ABO血型相容；(5) 再利用移植物的获取对象无经血液传播性疾病(细菌、真菌或病毒感染)。结合文献所报道的实际情况来看，该参考标准对再利用移植物的要求过于严苛，随着肝移植外科及器官保存技术、新型免疫抑制剂和围手术期管理水平的发展和进步，在肝移植物再利用的案例中，也包含一些年龄较大 [<xref ref-type="bibr" rid="hanspub.40549-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.40549-ref16">16</xref>]，再利用时间较晚 [<xref ref-type="bibr" rid="hanspub.40549-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.40549-ref18">18</xref>]，合并病毒性肝炎的供体 [<xref ref-type="bibr" rid="hanspub.40549-ref18">18</xref>] 以及辅助性肝移植物再利用 [<xref ref-type="bibr" rid="hanspub.40549-ref22">22</xref>] 等报道，亦取得了令人满意的效果。</p><p>如今，在器官移植的供体库中，边缘性供体(extended criteria donor，简称ECD)所占比例呈逐渐上升趋势 [<xref ref-type="bibr" rid="hanspub.40549-ref23">23</xref>] [<xref ref-type="bibr" rid="hanspub.40549-ref24">24</xref>]，而肝脏被认为是最利于重复使用的器官，其原因有：移植后慢性排斥反应发生率较低；免疫抑制药物引起肝损伤的情况少见；供体的年龄限制更为宽松 [<xref ref-type="bibr" rid="hanspub.40549-ref10">10</xref>]。而且，Kotecha S等人 [<xref ref-type="bibr" rid="hanspub.40549-ref25">25</xref>] 的研究亦表明，有些移植供体的确存在通过血液传播病毒(如HIV、HBV或HCV等，blood-borne virus，简称BBV)而导致受体感染的风险，但对于器官移植等待名单上的终末期肝病患者而言，若能有选择性的接受一些感染风险较低的移植器官，可降低其等待期死亡率而提高其生存率。</p><p>据2008年对于ECD的巴黎会议共识 [<xref ref-type="bibr" rid="hanspub.40549-ref26">26</xref>]：① 供体年龄没有绝对限制。② 应尽可能缩断肝移植物的短冷缺血时间。③ 对肝移植物进行病理活检以评估其脂肪化程度。④ 在某些少数情况下，感染BBV供体的移植物可以移植给具有相同病毒感染的受体或有紧急移植需求的终末期肝病患者；如接受合并细菌或真菌感染的移植物，受体在移植早期经适当抗生素治疗后可防止感染；而任何有转移性恶性肿瘤病史的供体均不应进行器官捐赠。⑤ 存在器质性病变但功能尚存的供体器官可以进行移植。⑥ 合并可逆性的功能障碍的供体器官可以进行移植等。结合本研究结果：在共计27例次的移植物再利用病例中，肝移植物的供体年龄范围为8~69岁；其脑死亡原因主要为脑外伤；第一接受者(亦是第二接受者的供体)的年龄范围为4~65岁，其最常见的脑死亡原因是移植后发生脑血管意外，其中还有2名合并丙型病毒性肝炎和1名乙型病毒性肝炎；再利用的中位冷缺血时间为3.9 h (0.4 h~12.4 h)。由此可见，再利用的肝移植物亦应属于边缘性供肝的范畴，可作为一种ECD的移植物供临床移植医师选择应用。</p></sec><sec id="s8_2"><title>4.2. 肝移植物再利用的适应证</title><p>在本研究人群中，肝移植物再利用的临床指征各不相同。到目前为止，还没有针对肝移植物再利用受体选择标准的统一共识。一项针对供肝分配的研究显示，对于终末期肝病模型(model for end-stage liver disease, MELD)评分 &gt; 20分的等待肝移植患者而言，若能尽快接受肝移植，相较于为接受标准供肝而需要漫长等待时间的患者，其1年生存率有明显提高，并且随着MELD评分的增高，接受ECD的肝移植患者其生存获益率也随之提高 [<xref ref-type="bibr" rid="hanspub.40549-ref27">27</xref>]。笔者认为，与ECD一样，再利用的肝移植物，通常取决于移植医师的综合判断和受体的需求程度，对于诸如一般状况较差、合并重度脂肪肝、复发性病毒性肝炎、暴发性肝功能衰竭或肝细胞癌分期近乎超出现行肝移植标准等某些特殊情况的终末期肝病患者而言，其病情较为危重，但进入肝移植等待名单又无法及时被分配到合适供体，此时，在没有明确禁忌症且能够及时获得再利用肝移植物的前提下，可考虑肝移植物再利用方案的可行性。</p></sec><sec id="s8_3"><title>4.3. 再利用肝移植物的预后和前景</title><p>据《2018年中国肝脏移植质量检测报告》 [<xref ref-type="bibr" rid="hanspub.40549-ref28">28</xref>] 数据显示，目前我国成人肝移植1年，3年和5年的总体生存率分别为84%，75%和71%，而在本研究共计27例次移植物的再利用的病例报道中，移植物再利用肝移植受体的术后1年，3年和5年总体生存率分别为92.4%，80.5%和64.4%，由此可见，尽管移植物再利用的肝移植总体例数较少，但其受体亦可获得较令人满意的预后，不过，考虑到全世界该方面的临床经验仍较为有限，尚不能确定是否应将脑死亡后移植受体的肝移植物纳入常规供体库当中。笔者认为，可将再利用的肝移植物视为一种稀有但有价值的资源，对其进行合理地评估和应用，既可缓解器官供体短缺并提高捐献器官的利用率，还可以使得更多的患者从中受益，提高生活质量和存活率。同理而言，在没有其他禁忌症的情况下，不仅是移植肝脏，其他的移植器官(心脏 [<xref ref-type="bibr" rid="hanspub.40549-ref29">29</xref>] 及肾脏 [<xref ref-type="bibr" rid="hanspub.40549-ref30">30</xref>] [<xref ref-type="bibr" rid="hanspub.40549-ref31">31</xref>] [<xref ref-type="bibr" rid="hanspub.40549-ref32">32</xref>] 等)也可用于等待移植的危重症患者。</p><p>据现有文献报道的临床经验来看，移植物再利用在肝移植领域应用的效果尚可，但仍需更大样本数据的支持。本研究属于通过文献检索进行的回顾性研究，存在样本量小、覆盖面窄及部分病例数据缺失等不足，只能初步了解目前国际上对于肝移植物再利用的大体情况。鉴于目前器官移植供体短缺、移植器官再利用的国内经验和认识不足等现状，我们希望本研究结果能引起器官移植领域的临床医师们对移植器官再利用的重视，并在条件允许的前提下，开展更多移植器官再利用相关的器官移植临床和基础研究。</p></sec></sec><sec id="s9"><title>文章引用</title><p>于 婷,饶 伟,党智萍,翟慧敏,孔心涓. 肝移植物再利用在肝移植术中的文献分析报告Literature Analysis Report of the Reuse of Liver Graft in Liver Transplantation[J]. 临床医学进展, 2021, 11(02): 617-625. https://doi.org/10.12677/ACM.2021.112090</p></sec><sec id="s10"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.40549-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">沈中阳. 中国肝移植的发展与创新[J]. 临床肝胆病杂志, 2019, 35(11): 2377-2385.</mixed-citation></ref><ref id="hanspub.40549-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Moreno González, E., Gómez, R., Gonzalez Pinto, I., et al. (1996) Reuse of Liver Grafts after Early Death of the First Recipient. World Journal of Surgery, 20, 309-312. &lt;br&gt;https://doi.org/10.1007/s002689900049</mixed-citation></ref><ref id="hanspub.40549-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Tantawi, B., Cherqui, D., Duvoux, C., et al. (1996) Reuse of a Liver Graft Five Days after Initial Transplantation. Transplantation, 62, 868-869. &lt;br&gt;https://doi.org/10.1097/00007890-199609270-00029</mixed-citation></ref><ref id="hanspub.40549-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Friedrich, J., Lange, R., Erhard, J., et al. (2010) Successful Regretting of a Transplanted Liver. Transplant International, 10, 245-246. &lt;br&gt;https://doi.org/10.1111/j.1432-2277.1997.tb00695.x</mixed-citation></ref><ref id="hanspub.40549-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Figueras, J., Pares, D., González, C., et al. (1997) Reuse of a Transplanted Liver. Transplant International, 10, 335-337. &lt;br&gt;https://doi.org/10.1111/j.1432-2277.1997.tb00714.x</mixed-citation></ref><ref id="hanspub.40549-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Rubay, R., Wittebolle, X., Ciccarelli, O., et al. (2003) Re-Use of a Liver Allograft; an Exceptional Opportunity to Enlarge the Organ Donor Pool. Transplant International, 16, 497-499.  
&lt;br&gt;https://doi.org/10.1111/j.1432-2277.2003.tb00355.x</mixed-citation></ref><ref id="hanspub.40549-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Pruvot, F.R., Roumilhac, D., Dharancy, S., et al. (2004) Re-Use of a Liver Graft and Multi-Organ Procurement from a Liver Transplant Patient. Transplant International, 17, 49-53. &lt;br&gt;https://doi.org/10.1111/j.1432-2277.2004.tb00384.x</mixed-citation></ref><ref id="hanspub.40549-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Ortiz, J., Reich, D.J., Manzarbeitia, C., et al. (2005) Successful Re-Use of Liver Allografts: Three Case Reports and a Review of the UNOS Database. American Journal of Transplantation, 5, 189-192.  
&lt;br&gt;https://doi.org/10.1111/j.1600-6143.2004.00635.x</mixed-citation></ref><ref id="hanspub.40549-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Castellote, J., Lladó, L., Xiol, X., et al. (2006) Successful Reuse of Liver Grafts after Death of the First Recipient. Clinical Transplantation, 20, 604-608. &lt;br&gt;https://doi.org/10.1111/j.1399-0012.2006.00524.x</mixed-citation></ref><ref id="hanspub.40549-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Tayar, C., Karoui, M., Laurent, A., et al. (2006) Successful Reuse of Liver Graft 13 Years after Initial Transplantation. Transplantation, 82, 1547-1548. &lt;br&gt;https://doi.org/10.1097/01.tp.0000228238.40172.2f</mixed-citation></ref><ref id="hanspub.40549-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Nafidi, O., Letourneau, R., Willems, B.E. and Lapointe, R.W. (2007) Reuse of Liver Graft from a Brain Dead Recipient. Clinical Transplantation, 21, 773-776. &lt;br&gt;https://doi.org/10.1111/j.1399-0012.2007.00724.x</mixed-citation></ref><ref id="hanspub.40549-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Olschewski, P., Fikatas, P., Pratschke, J., et al. (2009) Endoscopic Management of Biliary Obstruction after Successful Reuse of a Liver Graft. Annals of Transplantation Quarterly of the Polish Transplantation Society, 14, 51-54.</mixed-citation></ref><ref id="hanspub.40549-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Rentsch, M., Meyer, J., Andrassy, J., et al. (2010) Late Reuse of Liver Allografts from Brain-Dead Graft Recipients: The Munich Experience and a Review of the Literature. Liver Transplantation, 16, 701-704.  
&lt;br&gt;https://doi.org/10.1002/lt.22053</mixed-citation></ref><ref id="hanspub.40549-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Karabulut, K., Eris, C., Piskin, T., Kayaalp, C. and Yilmaz, S. (2012) Reuse of a Pediatric Liver Graft: A Case Report. Case Reports in Transplantation, 2012, Article ID: 350817. &lt;br&gt;https://doi.org/10.1155/2012/350817</mixed-citation></ref><ref id="hanspub.40549-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Desai, C.S., Khan, K.M. and Fishbein, T.M. (2013) Reuse of Liver Allografts from Brain-Dead Liver Transplant Recipients. Transplant International, 26, e43-e45. &lt;br&gt;https://doi.org/10.1111/tri.12079</mixed-citation></ref><ref id="hanspub.40549-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Tanaka, H., McAlister, V.C., Levstik, M.A., et al. (2014) Reuse of Liver Grafts Following the Brain Death of the Initial Recipient. World Journal of Hepatology, 6, 443-447. &lt;br&gt;https://doi.org/10.4254/wjh.v6.i6.443</mixed-citation></ref><ref id="hanspub.40549-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Balderramo, D., Eugenia Romero, M., Alcaraz, Á., Barrabino, M. and Maraschio, M. (2015) Reuse of a Transplanted Liver Graft: First Experience in South America. Liver Transplantation, 21, 269-271. &lt;br&gt;https://doi.org/10.1002/lt.24028</mixed-citation></ref><ref id="hanspub.40549-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Wong, T.C., She, W.H., Cheung, T.T., Chan, S.C. and Lo, C.M. (2015) Case Report of Relay Liver Transplantation with Graft Infected with Hepatitis B Virus. Transplantation Proceedings, 47, 2768-2770.  
&lt;br&gt;https://doi.org/10.1016/j.transproceed.2015.09.036</mixed-citation></ref><ref id="hanspub.40549-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Hu, X.G., Kim, I.G., Wang, H.J., et al. (2018) Reuse of Living-Donor Liver Graft in Second Recipient with Long-Term Survival. Transplantation Proceedings, 50, 3984-3987. &lt;br&gt;https://doi.org/10.1016/j.transproceed.2018.03.004</mixed-citation></ref><ref id="hanspub.40549-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Kim, M.J., Hwang, S., Jung, D.H., Park, G.C., Song, G.W., Cho, H.D. and Lee, S.G. (2020) Reuse of Liver Allograft from a Brain-Dead Recipient: A Case Report. Annals of Hepato-Biliary-Pancreatic Surgery, 24, 192-197.  
&lt;br&gt;https://doi.org/10.14701/ahbps.2020.24.2.192</mixed-citation></ref><ref id="hanspub.40549-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">The Joanna Briggs Institute (2016) Joanna Briggs Institute Reviewers Manual: 2016 Edition. The Joanna Briggs Institute, Adelaide.</mixed-citation></ref><ref id="hanspub.40549-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Ringers, J., Dubbeld, J., Baranski, A.G., et al. (2007) Reuse of Auxiliary Liver Grafts in Second Recipients with Chronic Liver Disease. American Journal of Transplantation, 7, 2615-2618.  
&lt;br&gt;https://doi.org/10.1111/j.1600-6143.2007.01959.x</mixed-citation></ref><ref id="hanspub.40549-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Vodkin, I. and Kuo, A. (2017) Extended Criteria Donors in Liver Transplantation. Clinics in Liver Disease, 21, 289-301. &lt;br&gt;https://doi.org/10.1016/j.cld.2016.12.004</mixed-citation></ref><ref id="hanspub.40549-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">孟海鹏, 高晶晶, 董汉光, 等. 边缘性供体肝移植的研究进展[J]. 中华肝胆外科杂志, 2019, 25(10): 789-794.</mixed-citation></ref><ref id="hanspub.40549-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Kotecha, S. and Williams, T.J. (2019) Extending the Criteria for Acceptable Organ Donors: Balancing the Risks. Medical Journal of Australia, 211, 402-403. &lt;br&gt;https://doi.org/10.5694/mja2.50370</mixed-citation></ref><ref id="hanspub.40549-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Durand, F., Renz, J.F., Alkofer, B., et al. (2008) Report of the Paris Consensus Meeting on Expanded Criteria Donors in Liver Transplantation. Liver Transplantation, 14, 1694-1707. &lt;br&gt;https://doi.org/10.1002/lt.21668</mixed-citation></ref><ref id="hanspub.40549-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Sass, D.A. and Reich, D.J. (2011) Liver Transplantation in the 21st Century: Expanding the Donor Options. Gastroenterology Clinics of North America, 40, 641-658. &lt;br&gt;https://doi.org/10.1016/j.gtc.2011.06.007</mixed-citation></ref><ref id="hanspub.40549-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">中国肝移植注册中心. 2018年中国肝脏移植质量检测报告[R]. 杭州: 中国肝移植注册中心, 2019.</mixed-citation></ref><ref id="hanspub.40549-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Pasic, M., Gallino, A., Carrel, T., et al. (1993) Brief Report: Reuse of a Transplanted Heart. The New England Journal of Medicine, 328, 319-320. &lt;br&gt;https://doi.org/10.1056/NEJM199302043280505</mixed-citation></ref><ref id="hanspub.40549-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Andrés, A., Morales, J.M. and Lloveras, J. (1993) Reuse of a Transplanted Kidney. The New England Journal of Medicine, 328, 1644. &lt;br&gt;https://doi.org/10.1056/NEJM199306033282220</mixed-citation></ref><ref id="hanspub.40549-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Tseng, W.H., Tian, Y.F., Liao, A.C., et al. (2018) Successful Reuse of a Transplanted Kidney 9 Years after Initial Transplantation: 4-Year Follow-Up. BMC Nephrology, 19, 234. &lt;br&gt;https://doi.org/10.1186/s12882-018-1040-0</mixed-citation></ref><ref id="hanspub.40549-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Veale, J.L., Lum, E.L., Cowan, N.G., et al. (2018) Donating Another Person’s Kidney: Avoiding the Discard of Organs by Retransplantation. Transplantation, 102, 2096-2100. &lt;br&gt;https://doi.org/10.1097/TP.0000000000002308</mixed-citation></ref></ref-list></back></article>